Related Experiment Videos
Disseminated intravascular coagulation with leukemia patients
1Anderson Cancer Institute, Texas Women's University, Houston, Texas.
Cancer Nursing
|December 1, 1993
Summary
Disseminated intravascular coagulation (DIC) is a complex bleeding and clotting disorder. This article details DIC pathophysiology and nursing care for leukemia patients, addressing unique coagulation challenges.
Area of Science:
- Hematology
- Pathophysiology
- Nursing Science
Background:
- Disseminated intravascular coagulation (DIC) is a critical condition characterized by simultaneous thrombosis and hemorrhage.
- Leukemia patients present unique challenges in DIC management due to pre-existing coagulation abnormalities.
Observation:
- DIC involves dysregulation of normal hemostasis, leading to widespread microvascular clotting.
- This pathological process consumes clotting factors and platelets, precipitating bleeding.
Findings:
- Understanding normal coagulation physiology is essential for recognizing DIC.
- Pathophysiology of DIC in leukemia involves complex interactions between malignancy and the coagulation cascade.
- Specific nursing diagnoses and interventions are crucial for managing leukemia patients with DIC.
Implications:
- Effective management requires a thorough understanding of DIC pathophysiology.
- Tailored nursing interventions can improve outcomes for leukemia patients experiencing DIC.
- Further research into leukemia-specific DIC management protocols is warranted.